Status and phase
Conditions
Treatments
About
To evaluate the efficacy of HRS9531 tablet compared with placebo in reducing body weight in obese subjects after 26 weeks of treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
166 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Qiannan Zhou
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal